Patent US5007897A successfully refreshed from Google Patents.
US5007897A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Drug delivery catheter
Assignee: Individual
•
Filing: 1989-05-30
•
Granted: 1991-04-16
•
Expires: 2009-05-30
Abstract
Abstract The invention comprises a system for the long term continuous delivery of medication to hollow body organs. It is particularly suited for the deivery of chemotherapy drugs to lesions in the walls of those organs. The invention, specially designed for the treatment of the prostate gland, comprises a urinary drainage catheter which has an additional lumen within the wall thereof, said lumen proximate end connected to a space external of the catheter wall enclosed by a porous membrane. The distal end of the lumen, which is external to the penis when the catheter is positioned in the body, has a valved end for introduction of liquid medication therethrough. In use, the catheter is placed within the urethra, with the porous membrane portion adjacent the prostatic ducts. Medication introduced through said valve is transmitted along the lumen into the space between the catheter and the porous membrane, through the membrane and into contact with the prostatic ducts.
Inventors
- 👤 Irvin M. Kalb
- 👤 Michael J. Ram
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 10:17
CPC Classifications
A; A61; A61M; A61M25/00; A61M25/10; A61M25/0043; A61M2025/0057; A61M2025/1043; A61M2025/105
Claims Analysis
Total Claims: 5
Claim 1
Independent Claim
231 words
A system for the controlled, continuous delivery over an extended period of time of a drug containing fluid to the prostate comprising a catheter including an elongated tubular member having an external distal end and a proximal end for placement into the urinary bladder through the male urethra, expandable means adjacent the proximal end to retain the catheter in sealing abutment against the neck of the bladder, an expandable porous membrane bag integral with and spaced from the outer surface of said tubular member, distal to the expandable means for retention of the catheter, a drug lumen within said tubular wall connecting the space between the outer surface of said tubular member and the membrane bag with a valve mounted on the distal end of the lumen for the introduction of the drug to the prostate, said membrane positioned so that upon placement of the catheter the membrane bag is adjacent the prostate ducts, the catheter having a lumen within the wall of said tubular member connecting the expandable retention means with a valve on the distal end of said tubular member the elongated tubular member also having a drainage lumen therein extending from the proximal end only partially along the length of the elongated member, the expansion lumen and the drug lumen for a portion of their length being enclosed within tubular members having semicircular crosssections and opposing flat surfaces.
Claim 2
Independent Claim
231 words
A system for the controlled, continuous delivery over an extended period of time of a drug containing fluid to the prostate comprising a catheter including an elongated tubular member having an external distal end and a proximal end for placement into the urinary bladder through the male urethra, expandable means adjacent the proximal end to retain the catheter in sealing abutment against the neck of the bladder, an expandable porous membrane bag integral with and spaced from the outer surface of said tubular member, distal to the expandable means for retention of the catheter, a drug lumen within said tubular wall connecting the space between the outer surface of said tubular member and the membrane bag with a valve mounted on the distal end of the lumen for the introduction of the drug to the prostate, said membrane positioned so that upon placement of the catheter the membrane bag is adjacent the prostate ducts, the catheter having a lumen within the wall of said tubular member connecting the expandable retention means with a valve on the distal end of said tubular member the elongated tubular member also having a drainage lumen therein extending from the proximal end only partially along the length of the elongated member, the expansion lumen and the drug lumen for a portion of their length being enclosed within tubular members having semicircular crosssections and opposing flat surfaces.
Claim 3
Dependent Claim
40 words
The catheter of claim 1 further having a sheath integral with said tubular member distal end, said sheath being condom shaped for leakproof covering of at least the meatus of the penis when the catheter is positioned in the urethra.
Claim 4
Dependent Claim
14 words
The catheter of claim 2 wherein said means for retention is an inflatable balloon.
Claim 5
Dependent Claim
29 words
The catheter of claim 1 further having the space between the porous membrane and the tubular member at least partially filled by an open pore compressible sponge like material.
References Cited (Backward Citations)
GB674134A
Cited
FR1280481A
Cited
US3394705A
Cited
US3598127A
Cited
US3593713A
Cited
US3699956A
Cited
US3981299A
Cited
US3815608A
Cited
US4062363A
Cited
US3977408A
Cited
US4186745A
Cited
US4553959A
Cited
US4417576A
Cited
US4623329A
Cited
DE3441586A1
Cited
US4710168A
Cited
WO1989003232A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-04-15 | 1994-10-15 | 1995-04-16 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-04-15 | 1998-10-15 | 1999-04-16 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-04-15 | 2002-10-15 | 2003-04-16 | $7700.00 | Window Closed / Lapsed |